CCAR2 and neoplasm: Thus, DBC1 is not only a pivotal regulator of CRC progression through acting as a tumor-promoting coactivator in multiple transcriptional pathways activated by Wnt/β-catenin signaling, but also a prognostic and therapeutic target for CRC.